BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,952 Cr | ₹-180 Cr | ₹3,823 Cr | ₹4,554 Cr | ₹3,390 Cr |
What is the latest Net Current Assets ratio of BIOCON ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹1,952 Cr |
| Mar2024 | ₹-180 Cr |
| Mar2023 | ₹3,823 Cr |
| Mar2022 | ₹4,554 Cr |
| Mar2021 | ₹3,390 Cr |
How is Net Current Assets of BIOCON Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,952 Cr | Positive | |
| Mar2024 | ₹-180 Cr | Negative | |
| Mar2023 | ₹3,823 Cr | -16.05 | |
| Mar2022 | ₹4,554 Cr | 34.33 | |
| Mar2021 | ₹3,390 Cr | - | |
Compare Net Current Assets of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹63,288.0 Cr | 0.2% | 5.9% | 27.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,628.0 Cr | 3.5% | 5.6% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,975.0 Cr | -1.3% | 4.5% | 16.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,804.0 Cr | -0.7% | 6.9% | 47.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,829.0 Cr | 1.3% | 5.1% | 17.5% | Stock Analytics | |
| CIPLA | ₹106,768.0 Cr | -1.9% | -0.3% | -6% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | 0.2% |
5.9% |
27.8% |
| SENSEX | -4.1% |
-5.8% |
5.8% |
You may also like the below Video Courses